Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
92.4M
-
Number of holders
-
258
-
Total 13F shares, excl. options
-
112M
-
Shares change
-
-1.32M
-
Total reported value, excl. options
-
$5.33B
-
Value change
-
-$71.6M
-
Put/Call ratio
-
0.41
-
Number of buys
-
141
-
Number of sells
-
-101
-
Price
-
$47.76
Significant Holders of Acadia Healthcare Company, Inc. - Common Stock (ACHC) as of Q3 2017
300 filings reported holding ACHC - Acadia Healthcare Company, Inc. - Common Stock as of Q3 2017.
Acadia Healthcare Company, Inc. - Common Stock (ACHC) has 258 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 112M shares
.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (11M shares), BlackRock Inc. (10.1M shares), WELLINGTON MANAGEMENT GROUP LLP (8.55M shares), JPMORGAN CHASE & CO (6.82M shares), VANGUARD GROUP INC (6.68M shares), Aristotle Capital Management, LLC (5.89M shares), GOLDMAN SACHS GROUP INC (4.1M shares), WELLS FARGO & COMPANY/MN (3.07M shares), FRONTIER CAPITAL MANAGEMENT CO LLC (2.57M shares), and FMR LLC (2.55M shares).
This table shows the top 258 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.